Mifamurtide for high-grade, resectable, nonmetastatic osteosarcoma following surgical resection: a cost-effectiveness analysis.
Johal, Sukhvinder
Mifamurtide for high-grade, resectable, nonmetastatic osteosarcoma following surgical resection: a cost-effectiveness analysis. [electronic resource] - Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research Dec 2013 - 1123-32 p. digital
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
1524-4733
10.1016/j.jval.2013.08.2294 doi
Acetylmuramyl-Alanyl-Isoglutamine--administration & dosage
Adjuvants, Immunologic--administration & dosage
Antineoplastic Combined Chemotherapy Protocols
Bone Neoplasms--drug therapy
Cost-Benefit Analysis
Humans
Markov Chains
Osteosarcoma--drug therapy
Phosphatidylethanolamines--administration & dosage
Quality-Adjusted Life Years
Mifamurtide for high-grade, resectable, nonmetastatic osteosarcoma following surgical resection: a cost-effectiveness analysis. [electronic resource] - Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research Dec 2013 - 1123-32 p. digital
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
1524-4733
10.1016/j.jval.2013.08.2294 doi
Acetylmuramyl-Alanyl-Isoglutamine--administration & dosage
Adjuvants, Immunologic--administration & dosage
Antineoplastic Combined Chemotherapy Protocols
Bone Neoplasms--drug therapy
Cost-Benefit Analysis
Humans
Markov Chains
Osteosarcoma--drug therapy
Phosphatidylethanolamines--administration & dosage
Quality-Adjusted Life Years